Counteracting CAR T cell dysfunction.

Poorebrahim, Mansour; Melief, Jeroen; Pico de Coaña, Yago; L Wickström, Stina; Cid-Arregui, Angel; Kiessling, Rolf

Poorebrahim, Mansour; Melief, Jeroen; Pico de Coaña, Yago; L Wickström, Stina; Cid-Arregui, Angel; Kiessling, Rolf.

Afiliação

Poorebrahim M; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. mansour.poorebrahim@dkfz-heidelberg.de.
Melief J; Targeted Tumor Vaccines Group, Clinical Cooperation Unit Applied Tumor Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany. mansour.poorebrahim@dkfz-heidelberg.de.
Pico de Coaña Y; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
L Wickström S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Cid-Arregui A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Kiessling R; Targeted Tumor Vaccines Group, Clinical Cooperation Unit Applied Tumor Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Oncogene ; 40(2): 421-435, 2021 01.

Article em En | MEDLINE | ID: mdl-33168929

Assuntos

Imunoterapia Adotiva/métodos; Linfócitos do Interstício Tumoral/imunologia; Neoplasias/terapia; Receptores de Antígenos de Linfócitos T/imunologia; Microambiente Tumoral/imunologia; Animais; Humanos; Neoplasias/imunologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Imunoterapia Adotiva / Linfócitos do Interstício Tumoral / Microambiente Tumoral / Neoplasias Limite: Animals / Humans Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google